A research team has developed a method to suppress the progression of non-small-cell lung cancer, potentially paving the way for a viable treatment of the disease, it said on Friday.
The team, which includes researchers from Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, gene edited a type of oncogenic ribonucleic acid (RNA) known as C190.
C190 plays a key role in causing non-small-cell carcinoma, which is the cause of 85 percent of lung cancer cases.
Photo: CNA
By combining RNA editing and gene therapy, the researchers dissected the function of C190 and tested its potential as a therapeutic, reducing proliferation and migration of the cancer-causing cells and suppressing tumor growth, the team said.
While C190 is relatively stable and unlikely to mutate, it might become a useful biomarker for the development of treatments of lung cancer caused by non-small-cell carcinoma, said Chiou Shih-hwa (邱士華), director of the hospital’s research center.
Chiou said that C190’s attributes could contribute to better treatments than the most commonly used method, which targets epidermal growth factor receptor (EGFR), a protein.
Photo courtesy of Linkou Chang Gung Memorial Hospital
Abnormal activation of EGFR is one of the most important driving forces for the malignancy of cancers, said the team, which published its findings in the American Association for Cancer Research journal in January.
While there have been three generations of EGFR-related medicines developed for clinical treatment of non-small-cell cancer, innate or acquired drug resistance within 12 months of the drug being administered is a roadblock created by EGFR’s high mutability, the team said.
One of the most prevalent forms of non-small-cell cancer is lung adenocarcinoma, which accounts for a majority of such patients in Taiwan.
In a separate study, researchers showed that the risk of stroke and heart attack for people with type-1 diabetes is increased 2.61 times if one or more of their close relatives have type-2 diabetes.
The diabetes study, which was conducted by researchers and doctors at Linkou Chang Gung Memorial Hospital, was published in the JAMA Network Open online medical journal in December last year.
The Chang Gung researchers found that for a person with type-1 diabetes who has a close relative with type-2 diabetes, the risk of renal disorder is increased 1.44 times, retinal disorder is 1.28 times more likely and neurological disorders are 1.24 times as common.
Linkou Chang Gung Memorial Hospital said in a news release that type-2 diabetes is not well understood, as it is much less prevalent than type-1, with just 1 percent of the 2 million diabetic Taiwanese having the type-2 condition.
Lead author Lin Chia-hung (林嘉鴻), a physician at the hospital’s department of endocrinology and metabolism, said that their research was the first-ever large-sample study into the implications of family health history for people with type-2 diabetes in Taiwan.
The two forms of diabetes are caused by insufficient production of insulin in the pancreas (type-1) and insulin resistance at the cellular level (type-2), Lin said.
Lin said that he began investigating possible relationships between risk factors after previous studies pointed to a correlation between being related to a person with diabetes, and increased risk of hyperinsulinemia, which is linked to type-2 diabetes, and clogged arteries.
The team showed that there was a correlation after working with the hospital’s analytics center to produce a model from the health histories of more than 10,000 people aged 20 or older who were diagnosed with diabetes, he said.
The findings can help guide doctors to assess the health risks of people with either form of diabetes, and facilitate preventive measures and timely treatment, he said.
South Korean K-pop girl group Blackpink are to make Kaohsiung the first stop on their Asia tour when they perform at Kaohsiung National Stadium on Oct. 18 and 19, the event organizer said yesterday. The upcoming performances will also make Blackpink the first girl group ever to perform twice at the stadium. It will be the group’s third visit to Taiwan to stage a concert. The last time Blackpink held a concert in the city was in March 2023. Their first concert in Taiwan was on March 3, 2019, at NTSU Arena (Linkou Arena). The group’s 2022-2023 “Born Pink” tour set a
CPBL players, cheerleaders and officials pose at a news conference in Taipei yesterday announcing the upcoming All-Star Game. This year’s CPBL All-Star Weekend is to be held at the Taipei Dome on July 19 and 20.
The Taiwan High Court yesterday upheld a lower court’s decision that ruled in favor of former president Tsai Ing-wen (蔡英文) regarding the legitimacy of her doctoral degree. The issue surrounding Tsai’s academic credentials was raised by former political talk show host Dennis Peng (彭文正) in a Facebook post in June 2019, when Tsai was seeking re-election. Peng has repeatedly accused Tsai of never completing her doctoral dissertation to get a doctoral degree in law from the London School of Economics and Political Science (LSE) in 1984. He subsequently filed a declaratory action charging that
The Hualien Branch of the High Court today sentenced the main suspect in the 2021 fatal derailment of the Taroko Express to 12 years and six months in jail in the second trial of the suspect for his role in Taiwan’s deadliest train crash. Lee Yi-hsiang (李義祥), the driver of a crane truck that fell onto the tracks and which the the Taiwan Railways Administration's (TRA) train crashed into in an accident that killed 49 people and injured 200, was sentenced to seven years and 10 months in the first trial by the Hualien District Court in 2022. Hoa Van Hao, a